Sabrina Valle and Gnaneshwar Rajan: Danaher, a $150 billion U.S. company that makes tools used in developing and testing medicines, on Tuesday agreed to buy Masimo for $9.9 billion, expanding in patient-monitoring devices in a surprise move outside its main focus. CNBC: Masimo’s non-invasive pulse oximeters will complement Danaher’s invasive Radiometer blood analyzer devices. […] […]